# Arcadia Biosciences, Inc. (RKDA)

> Basic Materials · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RKDA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.10M | $ -4.39M | $ -1.10M | $ 0 | $ 2.89M |
| 2025 | $ 4.97M | $ -2.39M | $ -4.85M | $ 0 | $ 4.14M |
| 2024 | $ 5.30M | $ -7.40M | $ -10.14M | $ 155.0K | $ 6.22M |
| 2023 | $ 5.40M | $ -15.12M | $ -16.54M | $ 1.01M | $ 12.84M |
| 2022 | $ 10.78M | $ -17.18M | $ -15.69M | $ 2.02M | $ 21.03M |
| 2021 | $ 8.06M | $ -17.43M | $ -31.95M | $ 3.29M | $ 31.09M |
| 2020 | $ 10.23M | $ -5.93M | $ -41.47M | $ 9.35M | $ 27.73M |
| 2019 | $ 1.51M | $ -37.18M | $ -24.10M | $ 2.24M | $ 7.71M |
| 2018 | $ 1.93M | $ -17.80M | $ -18.33M | $ 0 | $ 12.82M |
| 2017 | $ 5.42M | $ -21.16M | $ -18.92M | $ 0 | $ 8.01M |
| 2016 | $ 4.39M | $ -27.00M | $ -23.78M | $ 25.13M | $ 22.20M |
| 2015 | $ 7.60M | $ -25.21M | $ -21.43M | $ 24.93M | $ 40.23M |
| 2014 | $ 9.87M | $ -25.91M | $ -21.10M | $ 14.48M | $ -1.89M |
| 2013 | $ 9.21M | $ -18.77M | $ -14.00M | $ 14.56M | $ -17.30M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.85 |
| Current Ratio | 3.79 |

## Other views

- [Metrics](https://sponda.capital/en/RKDA.md)
- [Charts](https://sponda.capital/en/RKDA/charts.md)
- [Compare](https://sponda.capital/en/RKDA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.